Brief: Pharmaessentia Says To Buy 100% Forus Therapeutics For C$50 Mln
09/04/2026 11:06
April 9 (Reuters) - PharmaEssentia Corp 6446.TW: SAYS TO BUY 100% STAKE IN FORUS THERAPEUTICS INC FOR C$50 MILLION ($36.10 million) Source text: ID:nMOP7CMHQr Further company coverage: 6446.TW ($1 = 1.3852 Canadian dollars) (Reporting by Hong Kong newsroom) ((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on PHARMAESSENTIA
See all newsBrief: PharmaEssentia Announces Taiwan Approval Of BESREMi For Essential Thrombocythemia
Brief: Pharmaessentia Says Jan-Mar Net Profit T$2.15 Bln
Brief: Pharmaessentia Says To Buy 100% Forus Therapeutics For C$50 Mln
Brief: Pharmaessentia Signs Agreement For New Manufacturing Facility In Puerto Rico
Brief: Pharmaessentia Announces Japan Approval Of High-Dose Dosing Regimen For Besremi